Erlotinib in Combination With Docetaxel in Advanced Hepatocellular and Biliary Tract Carcinomas
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Sanofi
Related studies linked through entity extraction aliases.
A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
An Eight-week Study of Saredutant and Escitalopram as Combination Treatment for Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Insomnia and Daytime Function in Osteoarthritis
- Status
- COMPLETED
- Phase
- PHASE4
Effect of the Angiotensin II Receptor Antagonist Irbesartan on Biochemical and Functional Markers of Endothelial Dysfunction in Patients With Hypertension
- Status
- COMPLETED
- Phase
- PHASE4
Comparison of Apidra to Regular Insulin in Hospitalized Patients
- Status
- COMPLETED
- Phase
- NA
Study of Safety and Effectiveness of Apidra® in Combination With Basal Insulin in Patients With Type 1 & 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE4
Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel, Oxaliplatin and S-1 (DOS) for Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Combination Docetaxel and Radiotherapy With or Without Cisplatin to Treat Local Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Suicide Prevention by Lithium - the Lithium Intervention Study
- Status
- TERMINATED
- Phase
- NA
Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Evaluate Quality of Life in Type 2 Diabetes, Before and After Change to Insuline Glargine
- Status
- COMPLETED
- Phase
- PHASE4
Ischemia Driven Enoxaparin Therapy in ACS Presenting as Low Risk (IDEAL)
- Status
- TERMINATED
- Phase
- PHASE4
Docetaxel+Oxali+/-Cetux Met Gastric/GEJ
- Status
- COMPLETED
- Phase
- PHASE2
Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Participants With a Rising Prostate Specific Antigen (PSA)
- Status
- TERMINATED
- Phase
- PHASE3
Strategies to Treat Osteoporosis Following a Fragility Fracture
- Status
- COMPLETED
- Phase
- NA
Weekly Docetaxel Plus Cisplatin or Oxaliplatin for AGC
- Status
- UNKNOWN
- Phase
- PHASE2
Folfox-B Study for Patients With Colorectal Liver Metastases
- Status
- TERMINATED
- Phase
- PHASE2